These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36963351)

  • 1. Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer.
    Backman M; Strell C; Lindberg A; Mattsson JSM; Elfving H; Brunnström H; O'Reilly A; Bosic M; Gulyas M; Isaksson J; Botling J; Kärre K; Jirström K; Lamberg K; Pontén F; Leandersson K; Mezheyeuski A; Micke P
    Eur J Cancer; 2023 May; 185():40-52. PubMed ID: 36963351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer.
    Ino Y; Yamazaki-Itoh R; Shimada K; Iwasaki M; Kosuge T; Kanai Y; Hiraoka N
    Br J Cancer; 2013 Mar; 108(4):914-23. PubMed ID: 23385730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
    Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
    Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
    Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
    Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex immunofluorescence and single-cell transcriptomic profiling reveal the spatial cell interaction networks in the non-small cell lung cancer microenvironment.
    Peng H; Wu X; Liu S; He M; Xie C; Zhong R; Liu J; Tang C; Li C; Xiong S; Zheng H; He J; Lu X; Liang W
    Clin Transl Med; 2023 Jan; 13(1):e1155. PubMed ID: 36588094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional status and spatial interaction of T cell subsets driven by specific tumor microenvironment correlate with recurrence of non-small cell lung cancer.
    Yang L; Zhang W; Sun J; Yang G; Cai S; Sun F; Xing L; Sun X
    Front Immunol; 2022; 13():1022638. PubMed ID: 36685566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Using Multiplex Immunofluorescence.
    Peng H; Wu X; Zhong R; Yu T; Cai X; Liu J; Wen Y; Ao Y; Chen J; Li Y; He M; Li C; Zheng H; Chen Y; Pan Z; He J; Liang W
    Front Immunol; 2021; 12():750046. PubMed ID: 34804034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Consideration of Tumor-Associated Immune Cell Density and Immune Checkpoint Expression in the Peritumoral Microenvironment for Prognostic Stratification of Non-Small-Cell Lung Cancer Patients.
    Yang Y; Yang X; Wang Y; Xu J; Shen H; Gou H; Qin X; Jiang G
    Front Immunol; 2022; 13():811007. PubMed ID: 35222387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
    Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
    Yan Y; Wang X; Liu C; Jia J
    BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of CD39
    Koppensteiner L; Mathieson L; Pattle S; Dorward DA; O'Connor R; Akram AR
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37648263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer.
    Barua S; Fang P; Sharma A; Fujimoto J; Wistuba I; Rao AUK; Lin SH
    Lung Cancer; 2018 Mar; 117():73-79. PubMed ID: 29409671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer.
    Yim J; Koh J; Kim S; Song SG; Ahn HK; Kim YA; Jeon YK; Chung DH
    Eur J Cancer; 2020 Jul; 133():74-85. PubMed ID: 32447027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Cell Composition in Human Non-small Cell Lung Cancer.
    Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Front Immunol; 2018; 9():3101. PubMed ID: 30774636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional status and spatial architecture of tumor-infiltrating CD8+ T cells are associated with lymph node metastases in non-small cell lung cancer.
    Yang G; Cai S; Hu M; Li C; Yang L; Zhang W; Sun J; Sun F; Xing L; Sun X
    J Transl Med; 2023 May; 21(1):320. PubMed ID: 37173705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor immune microenvironment analysis of non-small cell lung cancer development through multiplex immunofluorescence.
    Zhao J; Lu Y; Wang Z; Wang H; Zhang D; Cai J; Zhang B; Zhang J; Huang M; Pircher A; Patel KH; Ke H; Song Y
    Transl Lung Cancer Res; 2024 Sep; 13(9):2395-2410. PubMed ID: 39430335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell immunophenotyping revealed the association of CD4+ central and CD4+ effector memory T cells linking exacerbating chronic obstructive pulmonary disease and NSCLC.
    Gémes N; Balog JÁ; Neuperger P; Schlegl E; Barta I; Fillinger J; Antus B; Zvara Á; Hegedűs Z; Czimmerer Z; Manczinger M; Balogh GM; Tóvári J; Puskás LG; Szebeni GJ
    Front Immunol; 2023; 14():1297577. PubMed ID: 38187374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood immune cell biomarkers in lung cancer.
    Riemann D; Cwikowski M; Turzer S; Giese T; Grallert M; Schütte W; Seliger B
    Clin Exp Immunol; 2019 Feb; 195(2):179-189. PubMed ID: 30246868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients.
    Mezheyeuski A; Bergsland CH; Backman M; Djureinovic D; Sjöblom T; Bruun J; Micke P
    J Pathol; 2018 Apr; 244(4):421-431. PubMed ID: 29282718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.